Prazosin for treatment of nightmares related to posttraumatic stress disorder

American Journal of Health-System Pharmacy

Volumn 65, Issue 8, 2008, Pages 716-722

  Taylor, Heather R ^a   Freeman, Maisha Kelly ^b   Cates, Marshall E ^b  

^a Walgreens' Pharmacy   (United States)

^b SAMFORD UNIVERSITY   (United States)

Author keywords

Dosage; Dreams; Hypotensive agents; Mechanism of action; Prazosin; Stress disorders; Toxicity

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CYPROHEPTADINE; ESCITALOPRAM; GABAPENTIN; MIRTAZAPINE; MOOD STABILIZER; NEFAZODONE; OLANZAPINE; PAROXETINE; PLACEBO; PRAZOSIN; PROPRANOLOL; PSYCHOTROPIC AGENT; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRAZODONE; VALPROIC ACID; VENLAFAXINE; ZOLPIDEM;

ANXIETY DISORDER; BEDTIME DOSAGE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISASTER; DIZZINESS; DRUG COST; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEADACHE; HUMAN; LETHARGY; MEDICAL RECORD REVIEW; MORNING DOSAGE; NAUSEA; NIGHTMARE; ORTHOSTATIC HYPOTENSION; PERSONAL EXPERIENCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SINUS TACHYCARDIA; SLEEP DISORDER; UNSPECIFIED SIDE EFFECT; VIOLENCE;

EID: 42349083127     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070124     Document Type: Review

References (29)

1. Anxiety disorders: post traumatic stress disorder. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association; 1994:424-9.
2. National Center for Post Traumatic Stress Disorder. What is PTSD? www.ncptsd.va.gov/ncmain/ncdocs/fact_shts/fs_faqs_on_ptsd.html (accessed 2008 Jan 10).
3. Schnurr PP, Friedman MJ, Bernardy NC. Research on posttraumatic stress disorder: epidemiology, pathophysiology, and assessment. J Clin Psychol. 2002; 58:877-89.
4. Anxiety disorders: post traumatic stress disorder. In: Hales RE, Yudofsky SC, eds. The American Psychiatric Publishing textbook of clinical psychiatry. 4th ed. Arlington, VA: The American Psychiatric Publishing; 2002:595-607.
5. Van Lieempt S, Vermetten E, Geuze E et al. Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature. Ann N Y Acad Sci. 2006; 1071:502-7.
6. Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact, and approaches to management. CNS Drugs. 2006; 20:567-90.
7. American Psychiatric Association. Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. www.psych.org/psych_pract/treatg/pg/ASD_PTSD_05-15-06.pdf (accessed 2007 Mar 2).
8. Daly CM, Doyle ME, Radkind M et al. Clinical case series: the use of prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans. Mil Med. 2005; 170:513-5.
9. Peskind ER, Bonner LT, Hoff DJ et al. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder. J Geriatr Psychiatry Neurol. 2003; 16:165-71.
10. Raskind MA, Dobie DJ, Kanter ED et al. The alpha-1 adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of four cases. J Clin Psychiatry. 2000; 61:129-33.
11. Taylor FT, Raskind MA. The alpha-1 adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol. 2002; 22:82-5.
12. Mosby's drug consult. St. Louis: Mosby; 2006:II-2371-3.
13. Raskind MA, Peskind ER, Kanter ED et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003; 160:371-3.
14. Griffith LJ. Case report: use of prazosin for treatment of posttraumatic stress disorder. Am Fam Physician. 2005; 72:758, 761. Letter.
15. Brkanac Z, Pastor JF, Storck M. Prazosin in PTSD. J Am Acad Child Adolesc Psychiatry. 2003; 42:384-5. Letter.
16. Raskind MA, Thompson C, Petrie EC et al. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry. 2002; 63:565-8.
17. Taylor FB, Lowe K, Thompson C et al. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biol Psychiatry. 2006; 59:577-81.
18. Guy W. Clinical Global Impressions (CGI) scale. In: Rush AJ, Pincus HA, First MB et al., eds. Handbook of psychiatric measures. 1st ed. Washington, DC: American Psychiatric Association; 2000:100-2.
19. Blake DD, Weathers FW, Nagy LN et al. The development of a clinician administered PTSD scale. J Trauma Stress. 1995; 8:75-80.
20. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-98.
21. Lehman E. Practicable and valid approach to evaluate the efficacy of drugs by means of rating scales. Pharmacopsychiatry. 1984; 17:71-85.
22. Micromedex Healthcare Series. Drug-dex evaluations: prazosin. www.thomsonhc.com.ezproxy.samford.edu/home/dispatch (accessed 2007 Mar 2).
23. Raskind MA, Peskind ER, Hoff DJ et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with posttraumatic stress disorder. Biol Psychiatry. 2007; 61:928-34.
24. Buysse DJ, Reynolds CF III, Monk TH et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28:193-213.
25. Laufer RS, Yager T, Frey-Wouters E et al. Legacies of Vietnam: comparing adjustment of veterans and their peers. Vol. 3. Washington, DC: U.S. Government Printing Office; 1981.
26. Krakow B, Schrader R, Tandberg D et al. Nightmare frequency in sexual assault survivors with PTSD. J Anxiety Disord. 2002; 16:175-90.
27. Lecrubier Y. Posttraumatic stress disorder in primary care: a hidden diagnosis. J Clin Psychiatry. 2004; 65(suppl 1):49-54.
28. Grinage BD. Diagnosis and management of post-traumatic stress disorder. Am Fam Physician. 2003; 68:2401-8.
29. Clinicaltrials.gov. www.clinicaltrials.gov (accessed 2007 Feb 21).